Next Science hit by Covid-19 shutdowns
Wound care technology developer Next Science was hit by shutdowns of elective surgeries and wound care clinics in the United States during the first six months of 2020, curbing revenue. Sales for the six months were $1.9 million, a small reduction on the previous corresponding period. Sales of Bactisure wound wash, BlastX anti-microbial wound gel…
Details